266 related articles for article (PubMed ID: 28159780)
1. Growth Differentiation Factor-15 and Risk of CKD Progression.
Nair V; Robinson-Cohen C; Smith MR; Bellovich KA; Bhat ZY; Bobadilla M; Brosius F; de Boer IH; Essioux L; Formentini I; Gadegbeku CA; Gipson D; Hawkins J; Himmelfarb J; Kestenbaum B; Kretzler M; Magnone MC; Perumal K; Steigerwalt S; Ju W; Bansal N
J Am Soc Nephrol; 2017 Jul; 28(7):2233-2240. PubMed ID: 28159780
[TBL] [Abstract][Full Text] [Related]
2. GDF-15, Galectin 3, Soluble ST2, and Risk of Mortality and Cardiovascular Events in CKD.
Tuegel C; Katz R; Alam M; Bhat Z; Bellovich K; de Boer I; Brosius F; Gadegbeku C; Gipson D; Hawkins J; Himmelfarb J; Ju W; Kestenbaum B; Kretzler M; Robinson-Cohen C; Steigerwalt S; Bansal N
Am J Kidney Dis; 2018 Oct; 72(4):519-528. PubMed ID: 29866459
[TBL] [Abstract][Full Text] [Related]
3. Growth differentiation factor-15 and incident chronic kidney disease: a population-based cohort study.
Bao X; Xu B; Borné Y; Orho-Melander M; Melander O; Nilsson J; Christensson A; Engström G
BMC Nephrol; 2021 Oct; 22(1):351. PubMed ID: 34706669
[TBL] [Abstract][Full Text] [Related]
4. Association between Plasma Levels of Growth Differentiation Factor-15 and Renal Function in the Elderly: Korean Frailty and Aging Cohort Study.
Kim JS; Kim S; Won CW; Jeong KH
Kidney Blood Press Res; 2019; 44(3):405-414. PubMed ID: 31163432
[TBL] [Abstract][Full Text] [Related]
5. Elevated circulating growth differentiation factor 15 is related to decreased heart rate variability in chronic kidney disease patients.
Wang L; Luo J; Liu W; Huang X; Xu J; Zhou Y; Jiang L; Yang J
Ren Fail; 2021 Dec; 43(1):340-346. PubMed ID: 33567936
[TBL] [Abstract][Full Text] [Related]
6. Growth differentiation factor-15 and fibroblast growth factor-23 are associated with mortality in type 2 diabetes - An observational follow-up study.
Frimodt-Møller M; von Scholten BJ; Reinhard H; Jacobsen PK; Hansen TW; Persson FI; Parving HH; Rossing P
PLoS One; 2018; 13(4):e0196634. PubMed ID: 29698460
[TBL] [Abstract][Full Text] [Related]
7. The Role of GDF-15 in Heart Failure Patients With Chronic Kidney Disease.
Benes J; Kotrc M; Wohlfahrt P; Conrad MJ; Franekova J; Jabor A; Lupinek P; Kautzner J; Melenovsky V; Jarolim P
Can J Cardiol; 2019 Apr; 35(4):462-470. PubMed ID: 30935637
[TBL] [Abstract][Full Text] [Related]
8. Change in novel filtration markers and risk of ESRD.
Rebholz CM; Grams ME; Matsushita K; Selvin E; Coresh J
Am J Kidney Dis; 2015 Jul; 66(1):47-54. PubMed ID: 25542414
[TBL] [Abstract][Full Text] [Related]
9. Growth Differentiation Factor 15 in Children with Chronic Kidney Disease and after Renal Transplantation.
Thorsteinsdottir H; Salvador CL; Mjøen G; Lie A; Sugulle M; Tøndel C; Brun A; Almaas R; Bjerre A
Dis Markers; 2020; 2020():6162892. PubMed ID: 32089755
[TBL] [Abstract][Full Text] [Related]
10. Growth Differentiation Factor-15 as a Predictor of Idiopathic Membranous Nephropathy Progression: A Retrospective Study.
Ham YR; Song CH; Bae HJ; Jeong JY; Yeo MK; Choi DE; Na KR; Lee KW
Dis Markers; 2018; 2018():1463940. PubMed ID: 29682097
[TBL] [Abstract][Full Text] [Related]
11. Biomarkers of cardiovascular stress and incident chronic kidney disease.
Ho JE; Hwang SJ; Wollert KC; Larson MG; Cheng S; Kempf T; Vasan RS; Januzzi JL; Wang TJ; Fox CS
Clin Chem; 2013 Nov; 59(11):1613-20. PubMed ID: 23873716
[TBL] [Abstract][Full Text] [Related]
12. Cognitive Impairment and Progression of CKD.
Kurella Tamura M; Yaffe K; Hsu CY; Yang J; Sozio S; Fischer M; Chen J; Ojo A; DeLuca J; Xie D; Vittinghoff E; Go AS;
Am J Kidney Dis; 2016 Jul; 68(1):77-83. PubMed ID: 26972681
[TBL] [Abstract][Full Text] [Related]
13. Circulating α-klotho levels in CKD and relationship to progression.
Kim HR; Nam BY; Kim DW; Kang MW; Han JH; Lee MJ; Shin DH; Doh FM; Koo HM; Ko KI; Kim CH; Oh HJ; Yoo TH; Kang SW; Han DS; Han SH
Am J Kidney Dis; 2013 Jun; 61(6):899-909. PubMed ID: 23540260
[TBL] [Abstract][Full Text] [Related]
14. Tissue transcriptome-driven identification of epidermal growth factor as a chronic kidney disease biomarker.
Ju W; Nair V; Smith S; Zhu L; Shedden K; Song PXK; Mariani LH; Eichinger FH; Berthier CC; Randolph A; Lai JY; Zhou Y; Hawkins JJ; Bitzer M; Sampson MG; Thier M; Solier C; Duran-Pacheco GC; Duchateau-Nguyen G; Essioux L; Schott B; Formentini I; Magnone MC; Bobadilla M; Cohen CD; Bagnasco SM; Barisoni L; Lv J; Zhang H; Wang HY; Brosius FC; Gadegbeku CA; Kretzler M;
Sci Transl Med; 2015 Dec; 7(316):316ra193. PubMed ID: 26631632
[TBL] [Abstract][Full Text] [Related]
15. Urinary neutrophil gelatinase-associated lipocalin may aid prediction of renal decline in patients with non-proteinuric Stages 3 and 4 chronic kidney disease (CKD).
Smith ER; Lee D; Cai MM; Tomlinson LA; Ford ML; McMahon LP; Holt SG
Nephrol Dial Transplant; 2013 Jun; 28(6):1569-79. PubMed ID: 23328709
[TBL] [Abstract][Full Text] [Related]
16. Association of Serum Ig Free Light Chains with Mortality and ESRD among Patients with Nondialysis-Dependent CKD.
Ritchie J; Assi LK; Burmeister A; Hoefield R; Cockwell P; Kalra PA
Clin J Am Soc Nephrol; 2015 May; 10(5):740-9. PubMed ID: 25825483
[TBL] [Abstract][Full Text] [Related]
17. GDF-15, iron, and inflammation in early chronic kidney disease among elderly patients.
Lukaszyk E; Lukaszyk M; Koc-Zorawska E; Bodzenta-Lukaszyk A; Malyszko J
Int Urol Nephrol; 2016 Jun; 48(6):839-44. PubMed ID: 27043030
[TBL] [Abstract][Full Text] [Related]
18. Soluble ST2 and Galectin-3 and Progression of CKD.
Alam ML; Katz R; Bellovich KA; Bhat ZY; Brosius FC; de Boer IH; Gadegbeku CA; Gipson DS; Hawkins JJ; Himmelfarb J; Kestenbaum BR; Kretzler M; Robinson-Cohen C; Steigerwalt SP; Tuegel C; Bansal N
Kidney Int Rep; 2019 Jan; 4(1):103-111. PubMed ID: 30596173
[TBL] [Abstract][Full Text] [Related]
19. NT-proBNP and troponin T and risk of rapid kidney function decline and incident CKD in elderly adults.
Bansal N; Katz R; Dalrymple L; de Boer I; DeFilippi C; Kestenbaum B; Park M; Sarnak M; Seliger S; Shlipak M
Clin J Am Soc Nephrol; 2015 Feb; 10(2):205-14. PubMed ID: 25605700
[TBL] [Abstract][Full Text] [Related]
20. Growth differentiation factor GDF-15 does not influence iron metabolism in stable chronic haemodialysis patients.
Li XY; Ying J; Li JH; Zhu SL; Li J; Pai P
Ann Clin Biochem; 2015 May; 52(Pt 3):399-403. PubMed ID: 25178559
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
